Cleveland Biolabs Inc (NASDAQ:CBLI)

3.37
Delayed Data
As of Feb 16
 -0.077 / -2.23%
Today’s Change
1.35
Today|||52-Week Range
5.55
-15.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-20.1M35.4K-13.0M-2.6M
 
 
 
 
 
Depreciation471.2K841.0K140.1K63.5K
 
 
 
 
 
Total Other Cash Flow-1.1M-15.9M2.3M-3.3M
 
 
 
 
 
Funds From Operations-20.8M-15.0M-10.6M-5.8M
 
 
 
 
 
Funds From/For Other Operating Expenses2.3M-559.5K1.4M-754.1K
 
 
 
 
 
Net Cash Flow - Operating Activities-23.1M-14.5M-12.1M-5.0M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-1.4M-16.9M-17.2M
 
 
 
 
Decrease In Investments2.2M1.7M3.6M22.7M
 
 
 
 
 
Capital Expenditures-139.5K-20.2K---10.2K
 
 
 
 
Fixed Asset Disposal----3.0M198.9K
 
 
 
Other Investing - Uses-1.5M-2.0M0.000.00
 
 
 
Net Cash Flow Investing560.7K-1.8M-10.3M5.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings7.3M-4.2M--0.00
 
 
 
Long Term Debt Reduction-78.1K-83.6K-2.7M0.00
 
 
 
 
Net Proceeds Stock Sale12.4K9.7M27.6M540.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.005.2M0.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing7.3M10.6M24.9M540.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-323.6K-1.3M235.6K-190.0K
 
 
 
 
 
 
Net Change In Cash-15.3M-5.7M2.6M1.2M